We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

160 hedge funds and large institutions have $1.95B invested in Agios Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.71% more ownership

Funds ownership: 103.31% → 109.02% (+5.7%)

2% less funds holding

Funds holding: 164 → 160 (-4)

13% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 32

23% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 61

31% less capital invested

Capital invested by funds: $2.81B → $1.95B (-$865M)

51% less call options, than puts

Call options by funds: $6.91M | Put options by funds: $14M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
160
Holders Change
-4
Holders Change %
-2.44%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
47
Reduced
61
Closed
32
Calls
$6.91M
Puts
$14M
Net Calls
-$7.06M
Net Calls Change
-$3.42M

Top Buyers

1
State Street
State Street
Massachusetts
+$24.2M
2
FCM
Farallon Capital Management
California
+$17.6M
3
EAM
Erste Asset Management
Austria
+$17.5M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$9.33M
5
EHI
Eagle Health Investments
Connecticut
+$7.89M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$56.9M
2
JP Morgan Chase
JP Morgan Chase
New York
-$46M
3
ClearBridge Investments
ClearBridge Investments
New York
-$42.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$15.2M
5
BlackRock
BlackRock
New York
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
176
Brown Advisory
Maryland
– -$203K -4,395 Closed
AII
177
AGF Investments Inc
Ontario, Canada
– -$194K -4,200 Closed
NICM
178
Neo Ivy Capital Management
New York
– -$149K -2,780 Closed
MAM
179
Meeder Asset Management
Ohio
– -$86K -1,871 Closed
PCM
180
Penserra Capital Management
California
– -$62K -1,355 Closed
DFCM
181
Dark Forest Capital Management
Puerto Rico
– -$17K -373 Closed
PA
182
Parallel Advisors
California
– -$1.77K -44 -83%
OSAM
183
O'Shaughnessy Asset Management
Connecticut
– -$2K -40 Closed
IA
184
IFP Advisors
Florida
– -$1K -29 Closed
CAPTRUST Financial Advisors
185
CAPTRUST Financial Advisors
North Carolina
– -$966 -24 -75%
TPCW
186
TD Private Client Wealth
New York
– -$508 -11 Closed
PNC Financial Services Group
187
PNC Financial Services Group
Pennsylvania
– -$322 -8 -16%
JWA
188
JFS Wealth Advisors
Pennsylvania
– +$81 +2 New
SC
189
Schubert & Co
Texas
– +$81 +2 New
Carson Wealth (CWM LLC)
190
Carson Wealth (CWM LLC)
Nebraska
– +$282 +7 New
4 5 6 7
8

AGIO Hedge Fund Activity: Q4 2021 in Review

160 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2021, worth a combined $1.95B — down 31% from $2.81B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of AGIO and 28 opened new positions — a net loss of 4 holders — while 61 trimmed existing stakes and 47 added.

The largest buyer was State Street, adding an estimated $24.2M. The largest seller was Fidelity Investments, cutting an estimated $56.9M.

  • 160 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2021, down from 164 in Q3 2021.
  • Funds reported $1.95B of Agios Pharmaceuticals stock for Q4 2021, down 31% quarter-over-quarter.
  • 28 funds opened new Agios Pharmaceuticals positions in Q4 2021 and 32 closed out, a net change of -4 holders.
  • The largest Agios Pharmaceuticals buyer in Q4 2021 was State Street, an estimated $24.2M added.
  • The largest Agios Pharmaceuticals seller in Q4 2021 was Fidelity Investments, an estimated $56.9M sold.

Based on aggregated 13F filings for Q4 2021.